Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanMyeloablative AgonistsTreatment OutcomeMultiple MyelomaStem CellsAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsVidarabineRetrospective StudiesAmyloidosisHematopoiesisSalvage TherapyLeukemiaIfosfamideSurvival RateVincristineSurvival AnalysisBlood CellsCarmustineGraft vs Leukemia EffectCytarabineHodgkin DiseaseTime FactorsLeukemia, Myeloid, AcutePlatelet CountMyelodysplastic SyndromesCytomegalovirus InfectionsAnemia, AplasticBlood Cell CountLymphomaCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionNeoplasmsFatal OutcomeFeasibility StudiesFollow-Up StudiesLivedo ReticularisHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsHematologic DiseasesDoxorubicinCyclosporinePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensBlood DonorsBone MarrowImmunophenotypingImmunosuppressionProspective StudiesRecombinant ProteinsMesenchymal Stem Cell TransplantationLymphoma, T-CellBone Marrow PurgingPilot ProjectsPrednisoneCarboplatinBone Marrow DiseasesAntigens, CDPrognosisBlood Group IncompatibilityAntineoplastic AgentsKidney TransplantationNeoplasm, Residual